Browse All

Current Filters

CLEAR FILTER x

TITLE

Impact of Aerobic Exercise on Non-Motor and Motor Symptoms of Parkinson’s Disease

Author:Flanigan, Joseph   Diane, Huss   Patrie, James   Dalrymple, William   Figari-Jordan, Renzo   Cain, Kristina   Barrett, Matthew   Shah, Binit   

Session Name:P6: Movement Disorders: Parkinson's Disease Management 2  

Topic:Movement Disorders  

Program Number:P6.006  

Author Institution:University of Virginia School of Medicine, Charlottesville, VA  University of Virginia, Charlottesville, VA  Virginia Commonwealth University, Richmond, VA  

Impact of Air Pollution on Disease Exacerbations in Central Demyelinating Disorders

Author:Teekaput, Chutithep   

Session Name:S8: Multiple Sclerosis: Imaging, Biomarkers, and Environmental Exposures  

Topic:Multiple Sclerosis  

Program Number:S8.005  

Author Institution:Mayo Clinic, Rochester, MN  

The Impact of Anxiety on Subjective and Objective Wakefulness in Warfighters With Insomnia

Author:Kapadia, Rayomand   Studnicki, Amanda   Metzger, Elizabeth   Akard, Claire   Cheraghpour, Ethan   Werner, J. Kent   

Session Name:P11: Sleep: Insomnia Research and Technology-driven Solutions  

Topic:Sleep  

Program Number:P11.007  

Author Institution:Uniformed Services University, MD  The Geneva Foundation, MD  Uniformed Services University, Bethesda, MD  

Impact of AXS-12 on Symptom Severity and Functional Impairment in Narcolepsy: Results From the Phase Three SYMPHONY Trial

Author:Thorpy, Michael   Krahn, Lois   Bogan, Richard   Corser, Bruce   Shapiro, Colin   Chen, Dan   Chhabra, Angad   Leary, Eileen   Tabuteau, Herriot   

Session Name:S3: Research Advances in Sleep and Clinical Impact  

Topic:Sleep  

Program Number:S3.008  

Author Institution:Montefiore Medical Center, Sleep-Wake Disorders Center, Bronx, NY  Mayo Clinic College of Medicine, Phoenix, AZ  Medical University of South Carolina, Charleston, SC  Intrepid Research, Cincinatti, OH  University of Toronto, Toronto, ON, Canada  Axsome Therapeutics, Inc., New York, NY  Formerly of Axsome Therapeutics, Inc., San Francisco, CA  

Impact of Baseline Sleep Disturbances on Pimavanserin Response in Parkinson’s Disease Psychosis: A Post Hoc Analysis

Author:Chrones, Lambros   Naujoks, Karla   Zhang, Peter   Feng, Xiaoshu   Brunson, Greg   Krystal, Andrew   

Session Name:P11: Aging, Dementia, and Behavioral Neurology: Synucleinopathies  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P11.007  

Author Institution:Acadia Pharmaceuticals, Inc., Westmont, IL  Acadia Pharmaceuticals, Inc., San Diego, CA  Acadia Pharmaceuticals, Inc., North Potomac, MD  Acadia Pharmaceuticals, Inc., San Clemente, CA  Departments of Psychiatry and Neurology, University of California - San Francisco, San Francisco, CA